BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 14985957)

  • 1. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Britti D; Patel NS; Di Paola R; Genovese T; Di Rosa M; Caputi AP; Thiemermann C
    Intensive Care Med; 2004 May; 30(5):951-6. PubMed ID: 14985957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein.
    Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Cuzzocrea S
    Immunology; 2006 Aug; 118(4):559-70. PubMed ID: 16764691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis.
    Virlos I; Mazzon E; Serraino I; Genovese T; Di Paola R; Thiemerman C; Siriwardena A; Cuzzocrea S
    Intensive Care Med; 2004 Aug; 30(8):1645-51. PubMed ID: 15168010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.
    Paterniti I; Mazzon E; Riccardi L; Galuppo M; Impellizzeri D; Esposito E; Bramanti P; Cappellani A; Cuzzocrea S
    Surgery; 2012 Jul; 152(1):90-106. PubMed ID: 22521259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein.
    Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Centorrino T; Ciccolo A; Van de Loo FA; Britti D; Caputi AP; Thiemermann C
    Shock; 2002 May; 17(5):416-22. PubMed ID: 12022764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis.
    Virlos I; Mazzon E; Serraino I; Di Paola R; Genovese T; Britti D; Thiemerman C; Siriwardena A; Cuzzocrea S
    Shock; 2003 Dec; 20(6):544-50. PubMed ID: 14625479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice.
    Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Menegazzi M; Malleo G; Suzuki H; Cuzzocrea S
    Shock; 2006 Feb; 25(2):161-7. PubMed ID: 16525355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein.
    Mazzon E; Genovese T; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Meli R; Sessa E; Cuzzocrea S
    Eur J Pharmacol; 2006 Nov; 549(1-3):149-56. PubMed ID: 16979620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis.
    Balachandra S; Genovese T; Mazzon E; Di Paola R; Thiemerman C; Siriwardena AK; Cuzzocrea S
    Surgery; 2005 Nov; 138(5):913-23. PubMed ID: 16291393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
    Minutoli L; Altavilla D; Marini H; Passaniti M; Bitto A; Seminara P; Venuti FS; Famulari C; Macrì A; Versaci A; Squadrito F
    Life Sci; 2004 Oct; 75(24):2853-66. PubMed ID: 15454338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation inhibition reduces NF-kappaB activation and attenuates cerulein-induced pancreatitis.
    Altavilla D; Famulari C; Passaniti M; Campo GM; Macrì A; Seminara P; Marini H; Calò M; Santamaria LB; Bono D; Venuti FS; Mioni C; Leone S; Guarini S; Squadrito F
    Free Radic Res; 2003 Apr; 37(4):425-35. PubMed ID: 12747737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in the development of cerulein-induced acute pancreatitis by treatment with M40401, a new selective superoxide dismutase mimetic.
    Cuzzocrea S; Genovese T; Mazzon E; Di Paola R; Muià C; Britti D; Salvemini D
    Shock; 2004 Sep; 22(3):254-61. PubMed ID: 15316396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein.
    Cuzzocrea S; Rossi A; Serraino I; Di Paola R; Dugo L; Genovese T; Britti D; Sciarra G; De Sarro A; Caputi AP; Sautebin L
    Immunology; 2003 Sep; 110(1):120-30. PubMed ID: 12941149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice.
    Cuzzocrea S; Malleo G; Genovese T; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Thiemermann C
    Crit Care Med; 2007 Dec; 35(12):2811-21. PubMed ID: 18074481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [B7-H3 monoclonal antibody attenuates the inflammation and tissue injury in mice with cerulein-induced acute pancreatitis].
    Zhuang X; Xu C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):323-7. PubMed ID: 26927550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gardenia jasminoides protects against cerulein-induced acute pancreatitis.
    Jung WS; Chae YS; Kim DY; Seo SW; Park HJ; Bae GS; Kim TH; Oh HJ; Yun KJ; Park RK; Kim JS; Kim EC; Hwang SY; Park SJ; Song HJ
    World J Gastroenterol; 2008 Oct; 14(40):6188-94. PubMed ID: 18985809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of interleukin-1 receptor antagonist (Anakinra) on cerulein-induced experimental acute pancreatitis in rats.
    Kaplan M; Yazgan Y; Tanoglu A; Berber U; Oncu K; Kara M; Demirel D; Kucuk I; Ozari HO; Ipcioglu OM
    Scand J Gastroenterol; 2014 Sep; 49(9):1124-30. PubMed ID: 24912987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial effect of propolis on cerulein-induced experimental acute pancreatitis in rats.
    Büyükberber M; Savaş MC; Bağci C; Koruk M; Gülşen MT; Tutar E; Bilgiç T; Deveci R; Küçük C
    Turk J Gastroenterol; 2009 Jun; 20(2):122-8. PubMed ID: 19530045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.